Analystreport

Sutro Biopharma Inc (NASDAQ: STRO) had its price target lowered by analysts at Piper Sandler from $23.00 to $20.00.

Sutro Biopharma, Inc.  (STRO) 
Last sutro biopharma, inc. earnings: 11/8 07:00 am Check Earnings Report